Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |